Patents by Inventor Kathryn Golden

Kathryn Golden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210374778
    Abstract: A user experience management system obtains survey results providing insight on the user's experience with provided products and services. Periodically, the user experience management system uses these results in conjunction with the help desk data and the user experience management system monitoring data to identify the set of problems with specific products and services on a granular level. The product management system generates a resolution to address a problem definition generated by the user experience management system. The user experience management system monitors the resolution and updates the database with data pertaining to the resolution. Other embodiments are disclosed herein.
    Type: Application
    Filed: June 2, 2021
    Publication date: December 2, 2021
    Inventors: Emily T. Schlick, Tyler Corbett, Clinton R. Laytham, Alexander Chea, Alison Bodker, Kalynn Clinton, Kathryn Golden
  • Patent number: 11020386
    Abstract: Abuse-resistant opioid compounds, drug delivery systems, pharmaceutical compositions comprising an opioid covalently bound to a chemical moiety are provided. Methods of delivering an active ingredient to a subject and methods of preventing opioid abuse are also provided.
    Type: Grant
    Filed: February 13, 2017
    Date of Patent: June 1, 2021
    Assignees: ALBANY MOLECULAR RESEARCH, INC., 3ST RESEARCH LLC
    Inventors: Matthew Surman, Kathryn Golden, Paolo Pasetto, Xiaomin Jin, Xiaowu Jiang, Fatoumata Camara, John K. Thottathil
  • Patent number: 10695342
    Abstract: Abuse-resistant opioid compounds, drug delivery systems, pharmaceutical compositions comprising an opioid covalently bound to a chemical moiety are provided. Methods of delivering an active ingredient to a subject and methods of preventing opioid abuse are also provided.
    Type: Grant
    Filed: February 13, 2017
    Date of Patent: June 30, 2020
    Assignees: ALBANY MOLECULAR RESEARCH, INC., 3ST RESEARCH LLC
    Inventors: Matthew Surman, John K. Thottathil, Kathryn Golden, Paolo Pasetto, Xiaomin Jin, Xiaowu Jiang, Fatoumata Camara
  • Publication number: 20170157116
    Abstract: Abuse-resistant opioid compounds, drug delivery systems, pharmaceutical compositions comprising an opioid covalently bound to a chemical moiety are provided. Methods of delivering an active ingredient to a subject and methods of preventing opioid abuse are also provided.
    Type: Application
    Filed: February 13, 2017
    Publication date: June 8, 2017
    Inventors: Matthew Surman, John K. Thottathil, Kathryn Golden, Paolo Pasetto, Xiaomin Jin, Xiaowu Jiang, Fatoumata Camara
  • Publication number: 20170151232
    Abstract: Abuse-resistant opioid compounds, drug delivery systems, pharmaceutical compositions comprising an opioid covalently bound to a chemical moiety are provided. Methods of delivering an active ingredient to a subject and methods of preventing opioid abuse are also provided.
    Type: Application
    Filed: February 13, 2017
    Publication date: June 1, 2017
    Inventors: Matthew Surman, Kathryn Golden, Paolo Pasetto, Xiaomin Jin, Xiaowu Jiang, Fatoumata Camara, John K. Thottathil
  • Publication number: 20160326182
    Abstract: Abuse-resistant opioid compounds, drug delivery systems, pharmaceutical compositions comprising an opioid covalently bound to a chemical moiety are provided. Methods of delivering an active ingredient to a subject and methods of preventing opioid abuse are also provided.
    Type: Application
    Filed: April 27, 2016
    Publication date: November 10, 2016
    Inventors: James Peltier, Matthew Surman, Kathryn Golden, Paolo Pasetto, Xiaomin Jin, Fatoumata Camara, Xiaowu Jiang
  • Publication number: 20140341843
    Abstract: The present invention provides methods and compositions for the preparation and delivery of chimeric cytokine proteins, including cell cultures, methods of purification and purified compositions.
    Type: Application
    Filed: July 27, 2012
    Publication date: November 20, 2014
    Applicant: ELEVEN BIOTHERAPEUTICS, INC.
    Inventors: Thomas M. Barnes, Jinzhao Hou, Gregory Zarbis-Papastoitsis, Emily Belcher Schirmer, Gary L. McNeil, Kathryn Golden